Congestive heart failure (CHF) accounts for more health care costs than any other diagnosis. Readmissions contribute to this expenditure. The authors evaluated the relationship between adherence to performance metrics and 30-day readmissions. This was a retrospective study of 6063 patients with CHF between 2001 and 2008. Data were collected for 30-day readmissions and compliance with CHF performance measures at discharge. Rates of readmission for CHF increased from 16.8% in 2002 to 24.8% in 2008. Adherence to performance measures increased concurrently from 95.8% to 99.9%. Except for left ventricular function (LVF) assessment, the 30-day readmission rate was not associated with adherence to performance measures. Readmitted patients had twice the odds of not having their LVF assessed (odds ratio = 2.0; P < .00005; 95% confidence interval = 1.45-2.63). CHF performance measures, except for the LVF assessment, have little relationship to 30-day readmissions. Further studies are needed to identify performance measures that correlate with quality of care.
Background : Growing numbers of American Veterans are diagnosed with psychological disorders and myocardial infarctions without known preexisting cardiac risk factors. Confronted with this information, we studied the association between psychological disorders and the presence of coronary artery calcium. High risk coronary calcification [Agatston method coronary artery calcium score (CAC) >100] is associated with a striking increase in cardiovascular events (hazard ratio>10) making it an excellent surrogate marker. Methods : From a database of VA patients who have undergone cardiac computed tomography, 483 were studied (age 59±12 years, 86% male). Regression analysis was utilized for comparison of CAC score for individuals with depression, anxiety, post-traumatic stress disorder (PTSD) and substance abuse.. Results : After adjustment for age, gender and cardiac risk factors, the odds ratio of CAC≥100 vs. CAC=0 was 1.24 (95% CI 1.02–2.08, p=0.044) for depression, 2.04 (95% CI 1.11– 6.17, p=0.027) for anxiety, 2.28 (95% CI 1.15–5.76, p=0.026) for PTSD and 2.61 (95% CI 1.14 – 6.03, p=0.022) for substance abuse as compared to normal cohort. Conclusion : Veterans with psychological disorders were found to have a significantly higher coronary artery calcification score than those without such disorders. These findings are independent of age, gender and other traditional cardiac risk factors.
Introduction Congestive heart failure (CHF) is the most costly disease in the US. Readmission costs contribute significantly to this healthcare expenditure. While adherence to published guidelines has increased, readmission rates have not improved. There is an urgent need to identify clinical and process measures that improve care for CHF patients. Thirty day readmission rates have often been used by third party payers as a surrogate index for quality of care in the inpatients settings. This study looked at the relationship between preadmission patient characteristics and 30 day readmissions. Methods: This was a single center retrospective case-control study that evaluated 6063 consecutive patients admitted with a diagnosis of CHF from December 2001 through December 2008. Data was abstracted for independent and dependent variables, including heart failure performance measures at discharge. This Ad hoc analysis focused on the relationship between patient determinants on 30 day readmissions. Statistical comparison was made between readmitted and non readmitted cohorts. Results: There were 6063 total patients admitted with the principal diagnosis of CHF. A total of 19.6% (1191 of 6063) of the patients were readmitted within 30 days of discharge. Another 19.9% (1211 of 6063) served as control cohort. The mean age for readmitted and non readmitted patients was 77.8(+/- 11.6) and 75.7 (+/- 11.8) years respectively. Mean duration of initial hospital stay for readmitted patients was 5.7 (+/- 4) days and 6.0 (+/-4) days for the control group. Readmitted patients were more likely to be smokers than their counterparts. (O.R= 1.5, 95% CI 1.2-1.9 p=0.002).Non usage of ACEI medication prior to hospitalization was associated with higher rates of readmission (O.R 1.30, 95% CI 1.1-1.6, p=0.003).However beta blocker therapy did not correlate with 30 day readmissions. (O.R 1.0, 95% CI 0.89- 1.19, p=0.970). Conclusions: In patients admitted with CHF, non usage of ACEI prior to hospitalization and smoking history may serve as indicators for early readmissions. Preadmission beta blocker use was not associated with reduced early readmissions. More studies need to be done to stratify determinants that identify patients at risk for early readmissions.
Introduction: The increasing implementation of transcatheter aortic valve implantation (TAVI) in various Australian centres warrants real-world data on the prevalence and outcomes of these patients. Methods: From the Centre-of-Health-Record-Linkage registry, all New South Wales residents who underwent TAVI in public and private facilities between 5-June,2013 and 30-June,2018 were identified. Public centres with an average TAVI caseload ,20 per-annum were classified as low-volume facilities. Private centres did not have individual facility identifier available and were classified as one category. Allcause mortality was tracked from the statewide death registry. Results: The study cohort comprised 1098 persons (mean [6SD] age: 83.367.7yrs; 58.8% males). 37.1% (407/1098 cases) were performed in public centres, and 53.3% (217/407 cases) of these were performed in low-volume centres. 62.9% (691/1098 cases) were performed in private centres. Proportion of cases performed in the public sector reduced from 83.3% in 2013 to 33.1% by 2017. In-hospital, 30-days and 180days all-cause mortality rates were 1.28%, 2.0% and 4.92% respectively. TAVI performed in low-volume compared to private or high-volume public centres was an independent predictor for all-cause mortality at 180-days (adjusted hazard ratio 3.49, 95% confidence interval 1.39-8.78, p=0.01). Conclusion: TAVI procedures are increasing, with a greater proportion of cases now performed in private centres. High-volume caseload may be an important determinant of patient outcomes.
Background: Congestive heart failure (CHF) is the most common Medicare diagnosis related group accounting for more healthcare costs than any other disease condition. Total annual healthcare expenditure for both direct and indirect healthcare cost of CHF approach 28 billion dollars. CHF readmissions contribute significantly to this expenditure. Quality of care in heart failure has been linked to clinical and process based performance measures. This study evaluated the relationship between adherence to heart failure performance metrics and 30 day readmission rates. Methods: This was a single center retrospective case-control study that evaluated 6063 consecutive patients admitted with a diagnosis of CHF from December 2001 through December 2008.Data was collected for readmission to the hospital within 30 days and compliance to the heart failure performance measures at discharge. Results: The rate of readmission for CHF increased steadily from 16.8% in 2002 to 24.8% in 2008, while adherence to the four CHF performance measures increased concurrently during the same time frame from 88.7% to 98.9%.Except for left ventricular function (LVF) assessment, 30 day readmission rate was not associated with adherence to any other performance measures. Readmitted patients had twice the odds of not having their LVF assessed (OR, 2.02; p<0.000016, 95% confidence interval 1.50-2.72) Conclusions: Heart failure performance measures, except for the assessment of left ventricular function have little relationship with 30 day hospital readmissions after discharge. More studies need to be done to identify performance measures that correlate with quality of care in heart failure patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.